The half maximal inhibitory concentrations (IC50) of TKIs for wild type KIT and KIT D816V assessed in patients with SM have been previously reported and representative values are shown for a variety of TKIs in Table 4 (90–96). The gene discussed is KIT; the disease is systemic mastocytosis.